MDM2 causes p53 to degrade and lose its tumor suppressive function [51], most likely by activating the JAK-STAT signaling pathway as a result of ICIs treatment, promoting the expression of IRF-8, which binds to the MDM2 promoter and causing MDM2 overexpression [52,53]. Here, TP53 is linked to neoplasm.